Article

Health-related quality of life for adults participating in outpatient substance abuse treatment.

The Center of Alcohol Studies, Rutgers, The State University of New Jersey, Piscataway 08854-8001, USA.
American Journal on Addictions (Impact Factor: 1.74). 05/2003; 12(3):198-210. DOI: 10.1111/j.1521-0391.2003.tb00648.x
Source: PubMed

ABSTRACT Interest exists in assessing health-related quality of life as one aspect of treatment effectiveness with substance abuse clients. The SF-36 Health Survey is a self-report measure assessing subjective health status along physical and mental health dimensions. Subjects were 252 adults in an outpatient, randomized clinical trial for substance abuse treatment. Subjects reported significantly more impairments in functioning when compared to U.S. population norms, but differences disappeared after three months of treatment. There was little support that quality of life functioning was significantly related to substance use during treatment. Results highlight the importance of using the SF-36 to facilitate treatment planning.

0 Bookmarks
 · 
59 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: RESUMO: A qualidade de vida é um conceito multidimensional que mede a saúde social, mental e física. Reconhecendo o número reduzido de investigações que examinam este conceito em sujeitos consumidores de drogas, considerou-se importante o estudo mais detalhado desta dimensão na população toxicodependente, procurando perceber se ela é mediada pelos programas de tratamento. Neste sentido, foram inquiridos 85 utentes em acompanhamento na consulta externa do CAT de Gaia, através dos seguintes instrumentos: MAP (Maudsley Addiction Profile), BSI (Inventário de Sintomas Psicopatológicos) e WHOQOL-bref (World Health Organization Quality of Life Assessment Instrument). Verificou-se que a integração em programas terapêuticos se constitui como elemento fundamental na melhoria da percepção que os indivíduos apresentaram em relação à sua qualidade de vida. Palavras-chave: Qualidade de vida; Toxicodependência; Programas e serviços. RÉSUMÉ: La qualité de vie est un concept multidimensionnel qui mesure la santé sociale, mentale et physique. Reconnaissant le nombre réduit investigations qui examinent ce concept dans des sujets con-sommateurs de drogues, on a considéré importantìétude plus détaillée de cette dimension dans la population toxicomane, en essayant de comprendre si elle est soutenue par les programmes de traitement. Dans ce sens, ont été enquêté 85 sujets en accompagnement dans la consultation externe du CentreAccompagnement aux Toxicomanes (CAT) de Gaia, en utilisant comme instruments le MAP (Maudsley Addiction Profile), BSI (Brief Symptom Inventory) et WHOQOL-bref (World Health Organization Quality of Life Assessment Instrument). On a vérifié que l´intégration dans des programmes thérapeutiques se constitue comme un élément fondamental dans l´amélioration de la perception que les individus présentent par rapport à sa qualité de vie. Mots-clé: Qualité de vie; Toxicomanie; Programmes et services. ABSTRACT: Quality of life is a multidimensional concept that measures social, mental and physical health. Acknowledged the reduced number of investigations that see into this concept in addicted individuals, it has been considered important the detailed study of this dimension in addicted population, seeking the understanding if it is interceded by the treatment programs. This being the case, eighty-five users in attendance were asked at the external consult at CAT of Gaia, through the following instruments: MAP (Maudsley Addiction Profile), BSI (Psychopathological Symptoms Inventory) and WHOQOL-bref (World Health Organization Quality of Life Assessement Instrument). It was confirmed that the integration in therapeutic programs consists itself as a fundamental element in the improvement of perception that the individuals show in relation to their quality of life.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To estimate variations in Overall Quality Of Life (OQOL) within 12 months following alcohol detoxification and to evaluate the predictive value of OQOL for relapse and alcohol use severity. Alcohol use disorders and four OQOL domains (physical health, psychological health, social relationships and environment) were assessed in 199 patients entering in-patient alcohol detoxification. Follow-up assessments were performed at 6 and 12 months after discharge. Cross-sectional and longitudinal analyses explored the relationship between OQOL and alcohol use severity, examining differences between abstinent and relapsed patients. The predictive value of OQOL was analyzed by logistic and linear regression. Correlation between OQOL and Alcohol Use Disorders Identification Test scores was confirmed at all stages of observation. Abstinent patients showed a significant improvement in all OQOL domains at 6 months after discharge, whereas OQOL domains did not undergo any significant change in relapsed patients. Baseline OQOL did not prove to be predictive of either relapse or alcohol use severity. Overall quality of life changed in parallel with alcohol use severity throughout the duration of the study, confirming it to be a useful and sensitive measure of secondary outcome for alcohol detoxification. Conversely, none of the OQOL baseline scores functioned as predictors of relapse within 12 months following discharge or alcohol use severity in relapsed patients.
    Quality of Life Research 06/2014; 23(10). DOI:10.1007/s11136-014-0735-3 · 2.86 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Improvement in quality of life (QOL) is a long term goal of drug treatment. Although some brief interventions have been found to reduce illicit drug use, no trial among adult risky (moderate non-dependent) drug users has tested effects on health-related quality of life. Methods A single-blind randomized controlled trial of patients enrolled from February 2011 to November 2012 was conducted in waiting rooms of five federally qualified health centers. 413 adult primary care patients were identified as risky drug users using the WHO-ASSIST and 334 (81% response; 171 intervention, 163 control) consented to participate in the trial. Three-month follow-ups were completed by 261 patients (78%). Intervention patients received the QUIT intervention of brief clinician advice and up to two drug-use health telephone sessions. The control group received usual care and information on cancer screening. Outcomes were three-month changes in the Short Form Health Survey (SF-12) mental health component summary score (MCS) and physical health component summary score (PCS). Results The average treatment effect (ATE) was non-significant for MCS (0.2 points, p-value = 0.87) and marginally significant for PCS (1.7 points, p-value = 0.08). The average treatment effect on the treated (ATT) was 0.1 (p-value = 0.93) for MCS and 1.9 (p-value = 0.056) for PCS. The effect on PCS was stronger at higher (above median) baseline number of drug use days: ATE = 2.7, p-value = 0.04; ATT = 3.21, p-value = 0.02. Conclusions The trial found a marginally significant effect on improvement in PCS, and significant and stronger effect on the SF-12 physical component among patients with greater frequency of initial drug use.
    Drug and Alcohol Dependence 09/2014; 142. DOI:10.1016/j.drugalcdep.2014.06.034 · 3.28 Impact Factor

Preview

Download
0 Downloads
Available from